-
公开(公告)号:EP4370149A1
公开(公告)日:2024-05-22
申请号:EP22842825.6
申请日:2022-07-13
CPC分类号: A61K39/39 , A61K2039/5555520130101 , A61K47/6903 , A61K47/60
-
公开(公告)号:EP4259188A2
公开(公告)日:2023-10-18
申请号:EP21904296.7
申请日:2021-12-08
-
公开(公告)号:EP4178675A1
公开(公告)日:2023-05-17
申请号:EP21836967.6
申请日:2021-07-08
-
公开(公告)号:EP4000228A1
公开(公告)日:2022-05-25
申请号:EP20840318.8
申请日:2020-06-11
发明人: IMRAN, Ali , FAROOQ, Hasan , ASGHAR, Ahmad
IPC分类号: H04L12/911 , H04W28/16 , G06N7/00
-
-
公开(公告)号:EP3650043A3
公开(公告)日:2020-07-29
申请号:EP19201178.1
申请日:2016-06-07
IPC分类号: A61K39/102 , C07H21/04 , C07K14/00 , C12P21/04 , A61P31/04 , C07K14/285
摘要: Immunogenic peptides, fusion polypeptides, and carrier molecules which include the immunogenic peptides, and immunogenic compositions which include these immunogenic peptides, fusion polypeptides, and/or carrier molecules bearing the peptides, and which are able to elicit antibody production against Haemophilus influenzae (Hi), are disclosed. Also disclosed are methods of their use in causing an antibody response against one or more strains of Hi.
-
-
公开(公告)号:EP3419988A1
公开(公告)日:2019-01-02
申请号:EP17757401.9
申请日:2017-02-26
-
公开(公告)号:EP3416635A1
公开(公告)日:2018-12-26
申请号:EP17753700.8
申请日:2017-02-14
发明人: DU, Lin , CICHEWICZ, Robert , NICHOLAS, Ken , YOU, Jianlan
IPC分类号: A61K31/19 , A61K31/215 , A61P17/04
CPC分类号: A61K31/215 , A61K31/336 , A61K31/365 , A61K31/40 , A61K31/4045 , A61K31/436 , A61K31/4412 , A61K31/4418
摘要: The present disclosure, in at least certain embodiments, is directed to shikimate (shikimic acid) analogues and compositions thereof, kits which contain the shikimate analogues or compositions thereof, and methods of use of the compounds and compositions for treating epithelial surfaces before or following exposure to irritants, allergens, and toxic agents (for example, urushiol).
-
公开(公告)号:EP3344276A1
公开(公告)日:2018-07-11
申请号:EP16843042.9
申请日:2016-09-02
摘要: Disclosed are synthetic peptides and peptide compositions, including peptide conjugates, that can ameliorate and/or block the cytotoxicity of C. difficile TcdB toxin, and methods of their use for inhibiting the activity of TcdB and protecting against damage during C. difficile disease, and/or for use as cell penetrating peptides for enhancing the delivery of particular heterogenous molecules into cells.
-
-
-
-
-
-
-
-
-